Watch for new payment when you perform HPV testing during cancer screening

Why This Topic Matters

The coverage change may affect preventive screening workflows, patient counseling, and reimbursement for practices that perform cervical cancer screening services under Medicare. Readers can use the article to determine whether the update applies to their setting and to prepare for future CMS billing guidance.

Article Sections

1. CMS coverage update and screening context

   Introduces the Medicare coverage change and the broader cervical cancer screening context. It also discusses general implementation considerations for practices and laboratories.

2. Specific testing guidelines and future coding guidance

   Summarizes the main CMS screening parameters discussed in the article and notes that additional coding and billing details are expected from CMS. This section focuses on the regulatory and operational framework rather than specific claim instructions.

3. Preventive service codes referenced in the article

   Identifies the preventive Pap smear codes mentioned alongside the screening update. The section presents them as part of the article’s reimbursement context.

4. Get familiar with HPV to boost compliance

   Discusses patient communication, screening compliance, and the importance of understanding HPV in the context of cervical cancer prevention. It also addresses how practices may frame the screening conversation.